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The patient was managed with injection enoxaparin 60 mg subcutaneously twice, intravenous mannitol 100 ml and tramadol 50 mg thrice, tablet Diamox 250 mg thrice, tablet oxcarbazepine 150 mg twice, broad-spectrum antibiotics, and supportive care.
COURSE IN THE HOSPITAL
On day 2, magnetic resonance (MR) imaging of the brain with MR venogram revealed extensive cerebral venous thrombosis (CVT) involving superior sagittal sinus, torcula, and bilateral cavernous sinuses [ Figure 1a and b]. Mucosal thickening of the right sphenoid sinus was seen. Investigations were sent for tumor marker studies and to rule out primary procoagulant state.
During the 1 st week, the patient complained of headache, left lower limb pain, and constipation. The cranial nerve palsies showed a fluctuating course with the appearance of palsies on the right side and reduction on the left side. Chest roentgenogram showed mild bibasilar atelectasis. Color Doppler studies of the lower limbs and renal vessels were normal. Day 20 Hemoglobin (14-18g/dL) On day 10, he developed right-sided lid edema with chemosis and left-sided hemiparesis. Repeat urgent NCCT of the brain showed diffuse cerebral edema with an iso/hyperdense lesion right supraorbital region, suggestive of possible hematoma or abscess. JAK2V617F mutation by amplification refractory mutation system-polymerase chain reaction was reported positive. Genetic thrombophilia screen including Factor V Leiden mutation, methylenetetrahydrofolate reductase, and prothrombin gene mutation was negative. Vasculitis screening and serum angiotensin-converting enzyme levels were normal.
On day 11, intrasinus thrombolysis was done and urokinase was started, which resulted in only partial recanalization. As optimal international normalized ratio was not achieved using warfarin, newer oral anticoagulants (dabigatran) were added.
On day 12, derangement in renal function was seen with rise in serum creatinine. On day 14, he had an episode of acute urinary retention, and postcatheterization, hematuria was noted. Ryle's tube aspiration brought out coffee ground gastric contents. Anticoagulant-associated coagulopathy was suspected. Heparin and oral anticoagulants were withheld. The patient was shifted to intensive care and administered 6 units of fresh frozen plasma and injection Vitamin K. Chest roentgenogram showed bilateral basal pleural effusion.
On day 15, gum hyperplasia was documented. Review by dental surgeon opined retained tooth stump. A biopsy was taken which later showed only necrotic tissue. His neurological state deteriorated further with the development of bilateral hemiparesis. Pedal edema was noted. Imaging of the chest and abdomen revealed bilateral pleural effusions with ascites. Repeat MRI of the brain showed extensive CVT with minimal recanalization. APTT became markedly prolonged and LDH showed marked increase [ Table 1 ]. Arterial blood gas analysis showed partly compensated metabolic acidosis. Antibiotics were upgraded.
On day 17, consultation with a nephrologist opined rapidly progressive renal failure. A differential diagnosis of (i) membranous glomerulonephritis/IgA nephropathy, (ii) catastrophic antiphospholipid syndrome (APS), (iii) disseminated malignancy, and (iv) sepsis syndrome were thought of. Specific anticardiolipin and anti-β2 glycoprotein-I IgG and IgM were negative. The patient could not be taken up for positron emission tomography (PET) computed tomography (CT) in view of deteriorating renal function. Intravenous methylprednisolone and immunoglobulin infusion resulted in dramatic improvement in clinical condition.
On day 18, renal biopsy and bone marrow aspiration and biopsy were performed. Oral anticoagulants and heparin were restarted.
Bone marrow aspiration showed dry tap; however, imprint smears showed predominant population of immature cells with cytoplasmic vacuoles (80%) [ Figure 1c ]. Sample could not be processed for flow cytometry immunophenotyping in view of dry tap. Peripheral smear showed leukoerythroblastic blood picture. On day 19, repeat imaging of the chest and abdomen revealed bilateral pleural effusions and ascites. A guided diagnostic ascitic tap showed exudative fluid with predominance of atypical lymphoid cells fluid (total cells -156,160/µL, white blood cells -122,880/µL, protein -2.7 g/dL, Alb -1.6/dL, LDH >5000 IU/L) with 90% atypical cells [ Figure 1d ]. Sample was processed for flow cytometry. Renal biopsy showed nonrepresentative tissue only. The same day, the patient became toxic with high fever, serositis, altered sensorium, tachycardia, and tachypnea. He continued to deteriorate further with drowsiness, dysarthria, rapidly progressive clinical ascites, and pleural effusion.
On day 21, the patient succumbed to his illness. A postmortem was performed.
UNIT'S FINAL DIAGNOSIS
Unit's final diagnosis was extensive cerebral vein thrombosis with JAK2V617F mutation-positive hematolymphoid malignancy.
DISCUSSION ON CLINICAL PROTOCOL
A young male, nonsmoker, with no known comorbidities, presented with extensive CVT with cranial nerve, cortical, and cerebellar signs. Primary procoagulant workup revealed positive APLA in low titers and moderate homocysteinemia. Extensive CVT in a young male is multifactorial and main causes are genetic prothrombotic risk factors, and secondary causes namely APS, hyperhomocysteinemia, malignancies, paraproteinemia, PNH, polycythemia vera, and certain drugs, e.g., L-asparaginase. [1, 2] In this patient, moderate homocysteinemia and APLA positivity were initially implicated in causation of stroke. However, specific anticardiolipin and anti-β2 glycoprotein-I IgG and IgM and genetic coagulation screen results were negative.
The patient had prolonged APTT since admission. This was attributed to LMW heparin and possible lupus anticoagulants. JAK2V617F mutation is present in 95%-98% of polycythemia vera, 50%-60% of primary myelofibrosis, and essential thrombocythemia. It is also described infrequently in other myeloid neoplasms, including chronic myelomonocytic leukemia and myelodysplastic syndrome. [3] In the absence of any hematologic finding, suggestive of a chronic myeloproliferative disorder, this positive result did not contribute to diagnosis.
Was it probable to explicate multisystem involvement on the basis of a single ailment? An acute thrombotic event may trigger the appearance of transient APLAs. [4, 5] Severe thrombosis and a dramatic improvement in clinical condition following steroids can be explained with an underlying malignancy as well. The learning lesson in this case was that PET-CT should have been performed earlier in the disease course.
The bone marrow study finally helped to clinch the diagnosis of acute leukemia. JAK2V617F mutation-positive acute leukemias are myeloid leukemias, are extremely rare, and reportedly comprise <5% of cases in data from many large studies, and more than half of these had a preceding MPD. [6, 7] The terminal event in the deceased was sepsis and multiorgan failure secondary to untreated acute leukemia.
FINAL CLINICAL DIAGNOSIS
Extensive CVT with etiological diagnosis of (b) paraneoplastic process due to JAK2V617F mutation-positive leukemia. Terminal event: Sepsis with multiorgan failure.
PATHOLOGY PROTOCOL BY ASSOCIATE PROFESSOR PATHOLOGY
An autopsy revealed bilateral hemorrhagic pleural and peritoneal effusions. The chest wall, the parietal pleura, and the manubriosternal joint showed fleshy hemorrhagic tumor nodules [ Figure 1e and f]. Thymus was enlarged and the right lung showed tumor-associated dense adhesions with the diaphragm. Nodularities were seen on the omentum [ Figure 1g ], abdominal wall, peritoneum, mesentery, appendices epiploicae [ Figure 1h ], mucosal surface of the stomach [Figure 2a ], and cecum [ Figure 2b ]. The liver and spleen were enlarged weighing 2.1 kg and 320 g, respectively; cut surfaces were congested; however, no focal or nodular lesions were seen [ Figure 2c and d]. Kidneys were enlarged with a left-sided perirenal hemorrhage (at the site of biopsy) [ Figure 2e and f]. The bladder wall was markedly thickened with dense adhesions of the bladder to perivesical tissue.
Falx cerebri showed cord-like thickening involving superior sagittal sinus, extending to inferior sagittal and transverse sinuses [ Figure 2g ]. Fleshy hemorrhagic thrombi were seen occluding the cerebral sinuses [ Figure 2h ]. Cut sections of the brain parenchyma, pericardium, heart, and great vessels were normal. Figure 3a -f], cerebral sinuses with proximal tubular necrosis of kidneys, and congestive changes in liver, lungs, and spleen.
Histopathologic examination revealed malignant hematolymphoid cells infiltrating all visceral organs [
Diagnosis of Burkitt lymphoma was confirmed by immunohistochemical expression of CD20, CD43, and CD10 with >95% Ki67 expression. Flow cytometry immunophenotyping of ascitic fluid revealed tumor cells positive for CD45, CD19, CD22, and CD79a with a monoclonal light chain expression of kappa. CD10, CD38, CD43, CD71, and bcl-6 were also expressed. The blast markers CD34 and TdT, myeloid, and T-cell markers were negative.
FINAL DIAGNOSIS
Final diagnosis was Burkitt Lymphoma with JAK2V617F mutation positivity.
CLINICOPATHOLOGICAL CORRELATION
Extensive cerebral venous sinus thrombosis in this patient was caused primarily by lymphomatous infiltration of cerebral sinuses. Although rare, this has been described in literature. [8] [9] [10] [11] [12] As the deceased had had no peripheral blood or lymph node involvement and a CNS dominant presentation, a sino-orbital disease with subsequent spread is more likely. Antemortem thrombectomy if submitted for histopathologic evaluation may have provided a clue. APLA positivity in low to moderate titers may occur in malignancies. [13] [14] [15] Further tumor-associated weakly positive LAs have also been described. This may also prolong APTT. Moderate homocysteinemia may be explained by depletion of folate and B12 due to tumor proliferation. JAK2V617F mutation positivity in non-Hodgkin's lymphoma has been reported in literature in sporadic case reports. [16] [17] [18] [19] To the best of our knowledge, this is the first report of this association in Burkitt lymphoma. It is possible that this coexistence portends a poorer prognosis.
Burkitt lymphoma has a very high doubling time of <24 h. Poor prognostic factors include primary CNS and marrow involvement at presentation and large disease burden which were present in this patient. [20] CONCLUSION Presentation of Burkitt lymphoma primarily with CNS involvement in the form of CVT is rare. This is the first report of JAK2V617F mutation positivity in Burkitt lymphoma. This case emphasizes the importance of early tumor workup a case of extensive cerebral sinus thrombosis. In a given patient, an exhaustive search for added etiologies should be done even when a specific risk factor is identified.
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Figure 3: (a) Section of bone marrow biopsy showing sheets of malignant lymphoid cells infiltrating the marrow spaces (H and E, ×400); (b) section of small intestine showing sheets of malignant lymphoid cells in serosa with normal overlying mucosa (H and E, ×100); (c) malignant lymphoid cells infiltrating the pericardium (H and E, ×100); (d) infiltration of renal capsule by lymphoid cells (H and E, ×100); (e) section of chest wall showing malignant lymphoid cells splitting skeletal muscle fibres (H and E, ×400); (f) medium-sized malignant lymphoid cells with markedly increased mitotic and apoptotic activity (H and E, ×400)
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